Brainstorm announces scientific presentation at the annual neals meeting

New york, sept. 30, 2020 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced the presentation of a poster titled, "advancing nurown® for als: phase 3 clinical trial design" at the...
BCLI Ratings Summary
BCLI Quant Ranking